Ocata Therapeutics Inc (OTCMKTS:OCAT) is one of the most sought after and trustworthy market leaders in the field of Regenerative Ophthalmology. The company has been trying different ways to enhance the standards of the medical science and cell technology in USA. The recent example of its achievement was seen when United States Patent and Trademark Office rewarded it with two new patents.
Insights On The Matter:
OCAT received two patents, numbers of which are 8,961,956 and 8,962,321. Both the patents have been rewarded to OCAT for developing the best in class Hemangio-derived Mesenchymal Cells technology, which can cure some of the deadly diseases of the world. Ocata Therapeutics Inc (OTCMKTS:OCAT)’s newly founded HMC technology is capable of taking the standards of cell therapy to new levels. According to reports, HMC has surely started a new era of the cell technology to cure diseases like ophthalmic, inflammatory and autoimmune.
With the help of HMC technology, Ocata Therapeutics Inc (OTCMKTS:OCAT) can generate unlimited delivery of potent HMCs from the most trustworthy source i.e. renewable pluripotent stem cell. These patents secure the manufacturing process of HMC technology as well as its usage for curing ophthalmic, inflammatory and autoimmune disease. No other company or individual can use this technology without OCAT’s permission.
The management of OCAT looks forward to making meaningful usage of this technology in the near future. According to Dr. Robert Lanza, MD, Chief Scientific Officer of Ocata Therapeutics Inc (OTCMKTS:OCAT), these immune-modulatory cells fall in the best inventions’ list of the company so far. They are very dynamic and capable of handling immune regulatory and anti-inflammatory activities in an effective way.
Dr. Lanza worked hard for months with other team members to invent HMC technology. According to him, HMC is capable of performing a lot better than the tradition treatments of mesenchymal stem cell therapies available in the world. It can surely bring a significant change and enhance the human capability to cure peculiar diseases.